Jonathan Peachey

Chief Operations Officer, Phesi

Articles

A Digital Twin on CAR-T Cytokine Release Syndrome (CRS) Patients with Standard of Care Measured by CRS Distribution by Grade

Gen Li, PhD, MBA;Jonathan Peachey;Paul Chew, MD;Peter M. O’Neill

May 26th 2023

Using existing clinical trial data to proactively model patient safety and efficacy outcomes could aid in accelerating development for areas in need of new therapies.

Leveraging Data Insights to Address the Perils of Linear Practices in Site Identification and Activation

Ken Getz, MBA;Zak Smith;Jonathan Peachey;Gen Li, PhD, MBA

October 18th 2022

Phesi and Tufts CSDD share results from research on operating practices that can be improved.

A Digital Twin on KRAS G12C NSCLC Patients with SCA Measured by PFS

Gen Li, PhD, MBA;Paul Chew, MD;Jonathan Peachey

April 22nd 2022

Digital twins, defined as a typical demographic patient profile in a specific population, have the potential to help clinical trial design.

Modal Value Guided Clinical Trial Design Effectively Reduces Protocol Amendments

Gen Li, PhD, MBA;Dan Manak;Jonathan Peachey

April 13th 2021

Analysis of 330,000 clinical trials calls for improved protocol design process.

Enrollment Cycle Times Can and Should Be Optimized

Gen Li, PhD, MBA;Karen Correa, PhD;Jonathan Peachey;Valerie Legagneur

January 17th 2018

Case study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.

Enrollment Cycle Times Can and Should Be Optimized

Gen Li, PhD, MBA;Karen Correa, PhD;Jonathan Peachey;Valerie Legagneur

January 17th 2018

Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.